Stay Updated with the Latest Reliance Global Group, Inc. RELIW News in Real Time
Find RELIW news now at Meyka AI. Stay informed with the latest Reliance Global Group, Inc. stocks updates, including price news, market analysis, and expert insights.
Who Runs the NDIS? NDIA, Approved Services and Choosing a Provider
Most people come to the NDIS with one simple question: who do I actually talk to? Behind every plan sits a chain of organisations, from Parliament to the therapist who knocks on your door. Each has a different job, and knowing those roles helps you get faster answers, make better choices and spot problems early….
Jacques Moretti Hearing: Crans-Montana Fire Questions Remain
Jacques Moretti faced nine hours of questions on Nov 2. We explain the Crans-Montana fire investigation and what comes next.
Guided Retirement: UK’s New Default Pension Plan Explained
Guided retirement would give 17 million UK workers a default pension that pays for life. See how it works and what changes.
Rena Lee ICJ Win: Singapore’s First World Court Judge
Rena Lee ICJ win makes her Singapore’s first World Court judge. See the vote count, her background and what it means.
Michael Jackson Estate Trust: Paris Jackson Seeks $600M
Michael Jackson estate trust: Paris Jackson asks a court to move $600M into the family trust. See what both sides say.
Bill Ackman AI Capex Call: Why He Backs the Hyperscalers
Bill Ackman AI capex view: Pershing Square says Big Tech’s $740B spending is offensive, not defensive. Key numbers inside.
Anthropic S-1 Filing Reveals $17B Q3 Revenue and $895B in Compute Deals
Anthropic S-1 filing shows $17B Q3 revenue, a $104B nine-month loss and $895B in compute deals. Here is what it means for investors.
Westpac Profit Slips 1% to $6.8B as RBA Lifts Rates
Westpac profit fell 1% to $6.8 billion in FY26 as costs, bad-loan charges and margins came under pressure. We explain the result, the 250 job cuts and the RBA rate hike to 4.85%.
Roche Share Price Dips After UBS Downgrade to Neutral
UBS cut Roche to Neutral on November 2 but raised its target to CHF 420. We explain why the Roche share price slipped to CHF 397.20, what giredestrant means and what analysts expect next.